Drug intelligence / Profile preview

beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide

Development stage: Unknown
Modality: Small Molecules

Overview

Beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide is a synthetic chemical compound with the molecular formula C23H29N3O2. It is classified as a pharmaceutical in databases like ZINC15. However, detailed information regarding its specific mechanism of action, primary indication, developers, manufacturers, and development status as a drug is not publicly available. It is likely a research compound or a lead compound in medicinal chemistry.

Other names: (2S)-1-[(2R)-2-amino-3,3-diphenylpropanoyl]-N-propylpyrrolidine-2-carboxamide

Targets

F2 (Thrombin)

Beyond the preview

Go deeper on beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide.

Explore the full profile